Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A serious metabolic condition caused by mutations in the MTHFR gene, medications, or nutritional deficiency. It results in increased levels of homocysteine in the blood. Patients with this condition are at an increased risk for recurrent blood clots formation and cardiovascular accidents.
Biomarker and diagnostic research for hyperhomocysteinemia has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
309 publications have been identified in PubMed for hyperhomocysteinemia. Kisho has analyzed 170 by research type. Research spans Review / Meta-Analysis (36%), Basic Science / Preclinical (26%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 62 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research | 44 | 26% |
Disease patterns and progression | 33 | 19% |
Testing and diagnosis research | 7 | 4% |
Patient case studies | 7 | 4% |
Other research | 6 | 4% |
Clinical study results | 6 | 4% |
New treatment approaches | 5 | 3% |
Guo L (2026). [PMID: 41615824](https://pubmed.ncbi.nlm.nih.gov/41615824/). *Ann Med*. [Review / Meta-Analysis]
Mohamed MSA (2026). [PMID: 42049165](https://pubmed.ncbi.nlm.nih.gov/42049165/). *Microvasc Res*. [Review / Meta-Analysis]
Prauchner GRK (2026). [PMID: 41360231](https://pubmed.ncbi.nlm.nih.gov/41360231/). *Biochem Pharmacol*. [Clinical Trial Publication]
Sinha U (2026). [PMID: 41503378](https://pubmed.ncbi.nlm.nih.gov/41503378/). *Schizophr Res Cogn*. [Epidemiology / Natural History]
Alabbi MN (2026). [PMID: 42260385](https://pubmed.ncbi.nlm.nih.gov/42260385/). *BMC Cardiovasc Disord*. [Review / Meta-Analysis]
Zhang L (2026). [PMID: 41960847](https://pubmed.ncbi.nlm.nih.gov/41960847/). *Nutr Hosp*. [Clinical Trial Publication]
Dutta BJ (2026). [PMID: 42120802](https://pubmed.ncbi.nlm.nih.gov/42120802/). *Biogerontology*. [Review / Meta-Analysis]
Brunner MS (2026). [PMID: 42220211](https://pubmed.ncbi.nlm.nih.gov/42220211/). *Dis Model Mech*. [Epidemiology / Natural History]
Suzuki T (2026). [PMID: 41535046](https://pubmed.ncbi.nlm.nih.gov/41535046/). *Intern Med*. [Case Report / Case Series]
Long ZP (2026). [PMID: 42231372](https://pubmed.ncbi.nlm.nih.gov/42231372/). *BMC Nutr*. [Review / Meta-Analysis]